Loss of Bcl2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity
1998

Bcl-2 Loss in Breast Cancer Linked to Cell Death and Growth

Sample size: 49 publication Evidence: high

Author Information

Author(s): H-J van Slooten, MJ van de Vijver, CJH van de Veldel, JH van Dierendonck

Primary Institution: Leiden University Medical Centre

Hypothesis

Does the expression of Bcl-2 in breast cancer correlate with rates of cell death and proliferation?

Conclusion

Loss of Bcl-2 expression in breast cancer is associated with increased cell death and higher proliferation rates.

Supporting Evidence

  • High Bcl-2 expression is associated with low rates of apoptotic and necrotic cell death.
  • Bcl-2-negative tumors showed a higher apoptotic index compared to Bcl-2-positive tumors.
  • High proliferation rates correlate with the absence of Bcl-2 expression.
  • Loss of Bcl-2 is linked to increased tumor grade.

Takeaway

In breast cancer, when a protein called Bcl-2 is missing, more cancer cells die, and the remaining cells grow faster.

Methodology

The study analyzed 49 breast cancer tumors for Bcl-2 expression and correlated it with apoptotic and necrotic cell death rates.

Limitations

The study focused only on tumors with extreme Bcl-2 expression levels, which may not represent all cases.

Participant Demographics

Premenopausal, lymph node-negative breast cancer patients.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication